134 related articles for article (PubMed ID: 35005523)
1. Outcomes of 23-Gauge Transconjunctival Sutureless Vitrectomy in Patients with Diabetic Retinopathy.
Pasaoglu I; Cakir M
Beyoglu Eye J; 2021; 6(3):243-248. PubMed ID: 35005523
[TBL] [Abstract][Full Text] [Related]
2. 25-Gauge transconjunctival sutureless pars plana vitrectomy.
Yanyali A; Celik E; Horozoglu F; Oner S; Nohutcu AF
Eur J Ophthalmol; 2006; 16(1):141-7. PubMed ID: 16496259
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of transconjunctival sutureless 23-gauge vitrectomy.
Kim MJ; Park KH; Hwang JM; Yu HG; Yu YS; Chung H
Korean J Ophthalmol; 2007 Dec; 21(4):201-7. PubMed ID: 18063883
[TBL] [Abstract][Full Text] [Related]
4. Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment.
Altan T; Acar N; Kapran Z; Unver YB; Ozdogan S
Retina; 2008 Oct; 28(9):1201-6. PubMed ID: 18728620
[TBL] [Abstract][Full Text] [Related]
5. Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy.
Ibarra MS; Hermel M; Prenner JL; Hassan TS
Am J Ophthalmol; 2005 May; 139(5):831-6. PubMed ID: 15860288
[TBL] [Abstract][Full Text] [Related]
6. Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery.
Fujii GY; De Juan E; Humayun MS; Chang TS; Pieramici DJ; Barnes A; Kent D
Ophthalmology; 2002 Oct; 109(10):1814-20. PubMed ID: 12359600
[TBL] [Abstract][Full Text] [Related]
7. Transconjunctival Sutureless 23-gauge Vitrectomy for Vitreoretinal Diseases: Outcome of 30 Consecutive Cases.
El-Batarny AM
Middle East Afr J Ophthalmol; 2008 Jul; 15(3):99-105. PubMed ID: 21369464
[TBL] [Abstract][Full Text] [Related]
8. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.
Yamamoto T; Hitani K; Tsukahara I; Yamamoto S; Kawasaki R; Yamashita H; Takeuchi S
Am J Ophthalmol; 2003 Jan; 135(1):14-9. PubMed ID: 12504691
[TBL] [Abstract][Full Text] [Related]
9. [23-gauge transconjunctival sutureless vitrectomy: a retrospective study of 164 consecutive cases].
de Preobrajensky N; Mrejen S; Adam R; Ayello-Scheer S; Gendron G; Rodallec T; Sahel JA; Barale PO
J Fr Ophtalmol; 2010 Feb; 33(2):99-104. PubMed ID: 20080319
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.
Park DH; Shin JP; Kim SY
Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):641-50. PubMed ID: 20012643
[TBL] [Abstract][Full Text] [Related]
11. A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery.
Oshima Y; Wakabayashi T; Sato T; Ohji M; Tano Y
Ophthalmology; 2010 Jan; 117(1):93-102.e2. PubMed ID: 19880185
[TBL] [Abstract][Full Text] [Related]
12. Transconjunctival sutureless vitrectomy for the treatment of vitreoretinal complications in patients with diabetes mellitus.
Yang SJ; Yoon SY; Kim JG; Yoon YH
Ophthalmic Surg Lasers Imaging; 2009; 40(5):461-6. PubMed ID: 19772269
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of 23- and 25-gauge transconjunctival sutureless vitrectomies for idiopathic macular holes.
Kusuhara S; Ooto S; Kimura D; Itoi K; Mukuno H; Miyamoto N; Akimoto M; Kuriyama S; Takagi H
Br J Ophthalmol; 2008 Sep; 92(9):1261-4. PubMed ID: 18614566
[TBL] [Abstract][Full Text] [Related]
14. Perfluorocarbon in vitreoretinal surgery and preoperative bevacizumab in diabetic tractional retinal detachment.
Arevalo JF; Serrano MA; Arias JD
World J Diabetes; 2014 Oct; 5(5):724-9. PubMed ID: 25317250
[TBL] [Abstract][Full Text] [Related]
15. Surgical outcomes of 25-gauge transconjunctival vitrectomy combined with cataract surgery for vitreoretinal diseases.
Oshima Y; Ohji M; Tano Y
Ann Acad Med Singap; 2006 Mar; 35(3):175-80. PubMed ID: 16625266
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of transconjunctival sutureless 27-gauge vitrectomy for vitreoretinal diseases.
Li J; Liu SM; Dong WT; Li F; Zhou CH; Xu XD; Zhong J
Int J Ophthalmol; 2018; 11(3):408-415. PubMed ID: 29600174
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Visual Outcomes and Safety Profile of 27-Gauge Pars Plana Vitrectomy for Posterior Segment Disease.
Khan MA; Kuley A; Riemann CD; Berrocal MH; Lakhanpal RR; Hsu J; Sivalingam A; Ho AC; Regillo CD
Ophthalmology; 2018 Mar; 125(3):423-431. PubMed ID: 29146307
[TBL] [Abstract][Full Text] [Related]
18. Primary 23-gauge vitreoretinal surgery for rhegmatogenous retinal detachment.
Yanyali A; Celik G; Dincyildiz A; Horozoglu F; Nohutcu AF
Int J Ophthalmol; 2012; 5(2):226-30. PubMed ID: 22762056
[TBL] [Abstract][Full Text] [Related]
19. A comparison of 23-gauge and 20-gauge vitrectomy for proliferative sickle cell retinopathy - clinical outcomes and surgical management.
Ho J; Grabowska A; Ugarte M; Muqit MM
Eye (Lond); 2018 Sep; 32(9):1449-1454. PubMed ID: 29786087
[TBL] [Abstract][Full Text] [Related]
20. Sutureless vitreoretinal surgery using a new 25-gauge transconjunctival system.
Yoon YH; Kim DS; Kim JG; Hwang JU
Ophthalmic Surg Lasers Imaging; 2006; 37(1):12-9. PubMed ID: 16468546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
